Centiva Capital, LP

Position in GRAL — GRAIL, Inc.

CIK 1692507 New York, NY

Back to GRAL Full portfolio

Position in GRAL

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$51,369

-$91,735 QoQ

Shares Held

994

-90.4% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in GRAL Over Time

Shares Held

Position Value (USD)

Derivatives in GRAL

reported options exposure · as of Mar 31, 2026

CallValue

$2,584,000

CallShares

50,000

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

Centiva Capital, LP holds $1,183,471 across 3 Diagnostics & Research names. GRAL ranks #3 (4.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LH	Labcorp Holdings Inc.	2,900	$773,749
2	A	Agilent Technologies, Inc.	3,144	$358,353
3	GRAL	GRAIL, Inc. This page	994	$51,369

All Filings in GRAL

Export CSV

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$51,369	994	-98.0%	Shares	Sole	2026-05-14
2026-03-31	$2,584,000	50,000	+380.8%	Call	Sole	2026-05-14
2024-09-30	$143,104	10,400	—	Shares	Sole	2024-11-14
No filing history on record for this holder in this stock.